Drug
AEF0117
AEF0117 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
50%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 22 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
NCT05322941
completedphase_1
Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects
NCT05554926
completedphase_2
Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
NCT03717272
completedphase_1
Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117
NCT03325595
Clinical Trials (4)
Showing 4 of 4 trials
NCT05322941Phase 2
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
NCT05554926Phase 1
Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects
NCT03717272Phase 2
Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
NCT03325595Phase 1
Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4